- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.75 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x AR6: [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL [HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE(Non-covalent)
- 2 x ZN: ZINC ION(Non-covalent)
ZN.2: 4 residues within 4Å:- Chain A: C.135, C.138, C.160, C.171
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:C.135, A:C.138, A:C.160, A:C.171
ZN.18: 4 residues within 4Å:- Chain B: C.135, C.138, C.160, C.171
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.135, B:C.138, B:C.160, B:C.171
- 2 x STL: RESVERATROL(Non-covalent)
STL.3: 13 residues within 4Å:- Chain A: I.55, P.56, D.57, F.58, V.64, F.76, F.80, V.109, D.110, M.151, I.179
- Ligands: AR6.1, PG4.4
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:I.55, A:F.58, A:F.76, A:F.80, A:V.109, A:V.109, A:I.179
- Hydrogen bonds: A:P.56
- Water bridges: A:V.109, A:D.110, A:D.110
STL.19: 13 residues within 4Å:- Chain B: I.55, P.56, D.57, F.58, V.64, F.76, F.80, V.109, D.110, M.151, I.179
- Ligands: AR6.17, PGE.20
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:I.55, B:F.58, B:F.58, B:F.76, B:F.80, B:V.109, B:V.109, B:I.179
- Hydrogen bonds: B:P.56, B:D.110
- Water bridges: B:V.109
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 9 x SO4: SULFATE ION(Non-functional Binders)
SO4.6: 4 residues within 4Å:- Chain A: H.62, K.75
- Chain B: H.62, K.75
6 PLIP interactions:3 interactions with chain B, 3 interactions with chain A- Hydrogen bonds: B:K.75, A:K.75
- Water bridges: B:K.75, A:K.75
- Salt bridges: B:H.62, A:H.62
SO4.7: 3 residues within 4Å:- Chain A: K.27, R.247, H.249
5 PLIP interactions:5 interactions with chain A- Water bridges: A:K.27, A:R.247
- Salt bridges: A:K.27, A:R.247, A:H.249
SO4.8: 6 residues within 4Å:- Chain A: R.84, A.269, W.270
- Chain B: R.84, A.269, W.270
7 PLIP interactions:5 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:W.270, A:W.270, B:W.270
- Water bridges: A:R.84, A:R.84
- Salt bridges: A:R.84, B:R.84
SO4.9: 3 residues within 4Å:- Chain A: R.199, R.225, R.226
2 PLIP interactions:2 interactions with chain A- Salt bridges: A:R.199, A:R.225
SO4.10: 3 residues within 4Å:- Chain A: R.214, P.215, N.218
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.214, A:N.218
SO4.11: 4 residues within 4Å:- Chain A: V.148, G.149, T.156, R.158
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:G.149
- Salt bridges: A:R.158
SO4.22: 4 residues within 4Å:- Chain B: E.23, K.27, R.247, H.249
4 PLIP interactions:4 interactions with chain B- Water bridges: B:H.249
- Salt bridges: B:K.27, B:R.247, B:H.249
SO4.23: 4 residues within 4Å:- Chain B: V.148, G.149, T.156, R.158
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:V.147, B:G.149
- Salt bridges: B:R.158
SO4.24: 3 residues within 4Å:- Chain B: R.214, P.215, N.218
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.218
- Salt bridges: B:R.214
- 6 x CL: CHLORIDE ION(Non-functional Binders)
CL.12: 3 residues within 4Å:- Chain A: R.97, L.280, L.283
Ligand excluded by PLIPCL.13: 4 residues within 4Å:- Chain A: T.79, F.80, E.81
- Ligands: PEG.16
Ligand excluded by PLIPCL.14: 3 residues within 4Å:- Chain A: L.72, A.73
- Chain B: H.62
Ligand excluded by PLIPCL.15: 2 residues within 4Å:- Chain A: H.62
- Chain B: A.73
Ligand excluded by PLIPCL.25: 3 residues within 4Å:- Chain B: P.74, K.75, F.76
Ligand excluded by PLIPCL.26: 4 residues within 4Å:- Chain B: T.79, F.80, E.81
- Ligands: EDO.5
Ligand excluded by PLIP- 1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- You, W. et al., Development of novel Sirtuin 6 inhibitors and activators based on a protein crystallography-based fragment screen. To Be Published
- Release Date
- 2024-03-06
- Peptides
- NAD-dependent protein deacetylase sirtuin-6: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.75 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x AR6: [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL [HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE(Non-covalent)
- 2 x ZN: ZINC ION(Non-covalent)
- 2 x STL: RESVERATROL(Non-covalent)
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 9 x SO4: SULFATE ION(Non-functional Binders)
- 6 x CL: CHLORIDE ION(Non-functional Binders)
- 1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- You, W. et al., Development of novel Sirtuin 6 inhibitors and activators based on a protein crystallography-based fragment screen. To Be Published
- Release Date
- 2024-03-06
- Peptides
- NAD-dependent protein deacetylase sirtuin-6: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B